A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV Melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hsp110-gp100 vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 18 May 2020 Biomarkers information updated
- 01 Mar 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Feb 2013 Planned initiation date changed from 1 Dec 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.